Krishna Institute of Medical Sciences Ltd announces Q2 results and key appointments
Krishna Institute of Medical Sciences · Healthcare Services
Key highlights
- Approved unaudited standalone and consolidated financial results for Q2 and half-year ended 30 Sept 2026 with limited review reports.
- Approved merger of wholly-owned subsidiary KIMS Hospitals Private Limited with Krishna Institute of Medical Sciences Limited.
- Reappointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as Chairman & Managing Director, and Ms. Dandamudi Anitha as Whole-time Director for terms of 5 years each.
Why it's rated notable: The filing approves quarterly results but states no profit or revenue figures, so the year-on-year change cannot be measured, and the subsidiary merger has no stated value and the director reappointments are management changes with no amount.
Original filing
Result For The Quarter Ended 30.09.2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Krishna Institute of Medical Sciences
- Acquisition / mergerNotableKrishna Institute of Medical Sciences approves Q2 financials and key reappointments
- Acquisition / mergerNotableKIMS announces acquisition of up to 51% stake in Insignia Healthcare Pvt Ltd
Other financial results filings this fortnight
- Lohia Corp Limited reports quarter results; Whole-time Director resigns
- Sadbhav Engineering Q2 results filed; statutory auditor Manubhai & Shah LLP resigns
- Investment Trust of India approves Sept 2026 half-year results; Shah named Manager
- Websol Energy approves H1 results and 40% subscription in Bright Earth Cell Pvt Ltd
- NHPC board approves unaudited results for quarter and half year ended 30 Sept 2026
- eMudhra Limited announces unaudited financial results for Q2 & H1 FY 2026-27
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.